Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H GILBERT

Showing results (741-750 of 824) with videos related to

Pageof 83
Sort By:
Chemmedchem|August 12, 2011
Optimisation of the anti-Trypanosoma brucei activity of the opioid agonist U50488Victoria C Smith, Laura A T Cleghorn, Andrew Woodland, et al.
Chemmedchem|January 20, 2011
Modified 5'-trityl nucleosides as inhibitors of Plasmodium falciparum dUTPaseGian Filippo Ruda, Corinne Nguyen, Przemysław Ziemkowski, et al.
Journal of Medicinal Chemistry|October 17, 2003
Azasterols as inhibitors of sterol 24-methyltransferase in Leishmania species and Trypanosoma cruziFilippo Magaraci, Carmen Jimenez Jimenez, Carlos Rodrigues, et al.
Journal of Medicinal Chemistry|September 30, 2015
Discovery of Indoline-2-carboxamide Derivatives as a New Class of Brain-Penetrant Inhibitors of Trypanosoma bruceiLaura A T Cleghorn, Sébastien Albrecht, Laste Stojanovski, et al.
Nature Communications|July 15, 2026
Genetic ancestry and monogenic disease risk in the Scottish Traveller founder populationAshwini Shanmugam, Benjamin S Fletcher, Maria Pala, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2021
Identification of a Proteasome-Targeting Arylsulfonamide with Potential for the Treatment of Chagas' DiseaseMarta L Lima, Lindsay B Tulloch, Victoriano Corpas-Lopez, et al.
European Journal of Medicinal Chemistry|February 7, 2025
Different chemical scaffolds bind to L-phe site in Mycobacterium tuberculosis Phe-tRNA synthetasePriyanka Gade, Changsoo Chang, Denise S Pryde, et al.
Cell Chemical Biology|March 10, 2021
Multiple unbiased approaches identify oxidosqualene cyclase as the molecular target of a promising anti-leishmanialLuciana S Paradela, Richard J Wall, Sandra Carvalho, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2004
Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasisSilvia Orenes Lorente, Juliany C F Rodrigues, Carmen Jiménez Jiménez, et al.
Journal of the American Board of Family Medicine : JABFM|November 11, 2018
Practitioner Participation in National Dental Practice-based Research Network (PBRN) Studies: 12-Year ResultsRahma Mungia, Ellen Funkhouser, Meredith K Buchberg Trejo, et al.
Pageof 83

Showing results (741-750 of 824) with videos related to

Sort By:
Pageof 83
Chemmedchem|August 12, 2011
Optimisation of the anti-Trypanosoma brucei activity of the opioid agonist U50488Victoria C Smith, Laura A T Cleghorn, Andrew Woodland, et al.
Chemmedchem|January 20, 2011
Modified 5'-trityl nucleosides as inhibitors of Plasmodium falciparum dUTPaseGian Filippo Ruda, Corinne Nguyen, Przemysław Ziemkowski, et al.
Journal of Medicinal Chemistry|October 17, 2003
Azasterols as inhibitors of sterol 24-methyltransferase in Leishmania species and Trypanosoma cruziFilippo Magaraci, Carmen Jimenez Jimenez, Carlos Rodrigues, et al.
Journal of Medicinal Chemistry|September 30, 2015
Discovery of Indoline-2-carboxamide Derivatives as a New Class of Brain-Penetrant Inhibitors of Trypanosoma bruceiLaura A T Cleghorn, Sébastien Albrecht, Laste Stojanovski, et al.
Nature Communications|July 15, 2026
Genetic ancestry and monogenic disease risk in the Scottish Traveller founder populationAshwini Shanmugam, Benjamin S Fletcher, Maria Pala, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2021
Identification of a Proteasome-Targeting Arylsulfonamide with Potential for the Treatment of Chagas' DiseaseMarta L Lima, Lindsay B Tulloch, Victoriano Corpas-Lopez, et al.
European Journal of Medicinal Chemistry|February 7, 2025
Different chemical scaffolds bind to L-phe site in Mycobacterium tuberculosis Phe-tRNA synthetasePriyanka Gade, Changsoo Chang, Denise S Pryde, et al.
Cell Chemical Biology|March 10, 2021
Multiple unbiased approaches identify oxidosqualene cyclase as the molecular target of a promising anti-leishmanialLuciana S Paradela, Richard J Wall, Sandra Carvalho, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2004
Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasisSilvia Orenes Lorente, Juliany C F Rodrigues, Carmen Jiménez Jiménez, et al.
Journal of the American Board of Family Medicine : JABFM|November 11, 2018
Practitioner Participation in National Dental Practice-based Research Network (PBRN) Studies: 12-Year ResultsRahma Mungia, Ellen Funkhouser, Meredith K Buchberg Trejo, et al.
Pageof 83